These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 22407922

  • 21. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis.
    Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M.
    J Immunol; 1991 Jul 15; 147(2):515-9. PubMed ID: 2071894
    [Abstract] [Full Text] [Related]

  • 22. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 23. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma.
    Klinman DM.
    J Immunol; 1990 Apr 01; 144(7):2529-34. PubMed ID: 2108205
    [Abstract] [Full Text] [Related]

  • 24. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M.
    Arthritis Rheum; 2005 Dec 01; 52(12):3987-96. PubMed ID: 16320345
    [Abstract] [Full Text] [Related]

  • 25. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus.
    Zeller GC, Hirahashi J, Schwarting A, Sharpe AH, Kelley VR.
    J Am Soc Nephrol; 2006 Jan 01; 17(1):122-30. PubMed ID: 16291836
    [Abstract] [Full Text] [Related]

  • 26. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B, Gee RJ, Kashgarian MJ, Sharpe AH, Mamula MJ.
    J Immunol; 1999 Aug 15; 163(4):2322-9. PubMed ID: 10438978
    [Abstract] [Full Text] [Related]

  • 27. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT, Madaio MP, Shlomchik MJ.
    J Immunol; 1999 Oct 01; 163(7):3592-6. PubMed ID: 10490951
    [Abstract] [Full Text] [Related]

  • 28. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
    Song YC, Tang SJ, Lee TP, Hung WC, Lin SC, Tsai CY, Ng WV, Wu MF, Sun KH.
    Arthritis Rheum; 2010 Aug 01; 62(8):2401-11. PubMed ID: 20506162
    [Abstract] [Full Text] [Related]

  • 29. OBF-1 is essential for the generation of antibody-secreting cells and the development of autoimmunity in MRL-lpr mice.
    Zuo J, Ge H, Zhu G, Matthias P, Sun J.
    J Autoimmun; 2007 Aug 01; 29(2-3):87-96. PubMed ID: 17574818
    [Abstract] [Full Text] [Related]

  • 30. Serum soluble MD-1 levels increase with disease progression in autoimmune prone MRL(lpr/lpr) mice.
    Sasaki S, Nagai Y, Yanagibashi T, Watanabe Y, Ikutani M, Kariyone A, Tsuneyama K, Hirai Y, Takatsu K.
    Mol Immunol; 2012 Jan 01; 49(4):611-20. PubMed ID: 22118968
    [Abstract] [Full Text] [Related]

  • 31. T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice.
    Monneaux F, Lozano JM, Patarroyo ME, Briand JP, Muller S.
    Eur J Immunol; 2003 Feb 01; 33(2):287-96. PubMed ID: 12548559
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A, Meghraoui-Kheddar A, Belmokhtar K, Vuiblet V, Ortillon J, Jaisson S, Devy J, Le Naour R, Tabary T, Cohen JH, Schmidt AM, Rieu P, Touré F.
    J Immunol; 2015 Apr 15; 194(8):3612-22. PubMed ID: 25762779
    [Abstract] [Full Text] [Related]

  • 34. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Muraoka M, Hasegawa H, Kohno M, Inoue A, Miyazaki T, Terada M, Nose M, Yasukawa M.
    Arthritis Rheum; 2006 Nov 15; 54(11):3591-600. PubMed ID: 17075801
    [Abstract] [Full Text] [Related]

  • 35. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR.
    J Immunol; 1998 Jul 01; 161(1):494-503. PubMed ID: 9647261
    [Abstract] [Full Text] [Related]

  • 36. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM, Yui MA, Endres S, Burt DW, Kelley VE.
    J Immunol; 1988 Jul 01; 141(1):118-24. PubMed ID: 3259964
    [Abstract] [Full Text] [Related]

  • 37. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R, Iwamoto M, Fossati L, Izui S.
    J Immunol; 1993 Dec 01; 151(11):6509-16. PubMed ID: 7902378
    [Abstract] [Full Text] [Related]

  • 38. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.
    Ma J, Xu J, Madaio MP, Peng Q, Zhang J, Grewal IS, Flavell RA, Craft J.
    J Immunol; 1996 Jul 01; 157(1):417-26. PubMed ID: 8683147
    [Abstract] [Full Text] [Related]

  • 39. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S.
    J Clin Invest; 1996 Apr 01; 97(7):1597-604. PubMed ID: 8601623
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.